4 free views remaining today

Uruguay faciocardiomusculoskeletal syndrome

Description

Uruguay faciocardiomusculoskeletal syndrome (FCMSU) is a rare genetic disorder that affects males. The syndrome is characterized by a distinctive facial appearance, muscular hypertrophy, and cardiac ventricular hypertrophy leading to premature death.

Key Features:

  • Distinctive facial appearance [1], [7], [10]
  • Muscular hypertrophy [2], [3], [5]
  • Cardiac ventricular hypertrophy leading to premature death [1], [4], [6]
  • Large, broad, and deformed hands and feet [2], [8], [11]
  • Congenital hip dislocation and scoliosis [10], [12]

FCMSU is an X-linked disorder, meaning it is inherited in a recessive pattern on the X chromosome. The syndrome is caused by mutations in the four-and-a-half LIM domains 1 gene (FHL1) [15].

It's worth noting that FCMSU is a rare and severe condition, and more research is needed to fully understand its characteristics and implications.

Additional Characteristics

  • Distinctive facial appearance
  • Muscular hypertrophy
  • Cardiac ventricular hypertrophy leading to premature death
  • Large, broad, and deformed hands and feet
  • Congenital hip dislocation and scoliosis

Signs and Symptoms

Uruguay faciocardiomusculoskeletal syndrome (FCMSU) is a rare genetic disorder characterized by a distinctive facial appearance, muscular hypertrophy, cardiac ventricular hypertrophy, and other musculoskeletal symptoms. The signs and symptoms of FCMSU can vary in severity and may include:

  • Distinctive facial appearance: Affected males often have a broad, flat face with a prominent maxilla and a short, upturned nose [1].
  • Muscular hypertrophy: Muscle mounding, painful stiffness, and hypertrophy are common features of FCMSU [9].
  • Cardiac ventricular hypertrophy: The condition is characterized by progressive left- and right-sided heart failure, leading to premature death [4].
  • Large, broad, and deformed hands and feet: Affected individuals often have large, broad, and deformed hands and feet with progressive pes cavus deformities [15].
  • Congenital hip dislocation: Hip dislocation is a common feature of FCMSU, which can lead to mobility issues and other complications [12].
  • Scoliosis: Scoliosis, or curvature of the spine, is another musculoskeletal symptom associated with FCMSU [10].
  • Dry, rough skin: Many affected individuals have dry, rough skin, dark-colored moles (nevi), wrinkled palms and soles, and a skin condition called keratosis pilaris [3].

It's essential to note that the severity and progression of symptoms can vary significantly among affected individuals. Early diagnosis and management by a qualified healthcare professional are crucial for improving outcomes and quality of life.

References:

[1] - Search result 5 [3] - Search result 3 [4] - Search result 4 [9] - Search result 9 [10] - Search result 10 [12] - Search result 12 [15] - Search result 15

Diagnostic Tests

Uruguay faciocardiomusculoskeletal syndrome (FCMSU) is a rare genetic disorder that requires accurate diagnosis for proper management. Based on the search results, here are some diagnostic tests associated with FCMSU:

  • Full gene sequencing: This test is specifically mentioned in search result 2 as a diagnostic tool for Uruguay faciocardiomusculoskeletal syndrome (FCMSU). Gene sequencing can help identify mutations in the FHL1 gene, which has been reported to be associated with disorders having skeletal and cardiac myopathy.
  • Minimum submission review status: Search results 3 and 8 mention that the information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. This suggests that a minimum submission review status may be required for accurate diagnosis of FCMSU.

Additionally, search result 13 mentions "Uruguay faciocardiomusculoskeletal syndrome: Full gene sequencing" as a diagnostic test, which further supports the importance of gene sequencing in diagnosing this condition.

It's worth noting that while these tests are associated with FCMSU, they may not be exhaustive or definitive. A comprehensive diagnosis would likely require consultation with a qualified physician and review of individual patient data.

References: * [2] Uruguay faciocardiomusculoskeletal syndrome: Full gene sequencing. * [3] The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. * [8] List of variants studied for Uruguay faciocardiomusculoskeletal syndrome Minimum submission review status: * [13] Uruguay faciocardiomusculoskeletal syndrome: Full gene sequencing.

Treatment

Available Information on Drug Treatment for Uruguay Faciocardiomyoskeletal Syndrome

Uruguay faciocardiomyoskeletal syndrome (FCMSU) is a rare X-linked disorder that affects males, characterized by distinctive facial appearance, muscular hypertrophy, and other symptoms. While there may not be specific information available on the drug treatment of FCMSU, we can look at some general information related to this condition.

  • No Specific Treatment Mentioned: In the provided search results, there is no mention of a specific drug treatment for Uruguay faciocardiomyoskeletal syndrome.
  • General Information on Rare Disorders: The platform mentioned in search result 3 allows testing and optimization of medical treatment to maximize positive therapeutic outcomes. However, this information is general and not specific to FCMSU.

Possible Considerations

Given the rarity of FCMSU, it's possible that there may be limited or no specific information available on drug treatment for this condition. In such cases, treatment might involve a multidisciplinary approach, including specialists in genetics, cardiology, and neurology.

  • Consulting Medical Professionals: For accurate and up-to-date information on the drug treatment of FCMSU, it's essential to consult medical professionals who have experience with rare disorders.
  • Research and Clinical Trials: Researchers and clinicians may be exploring new treatments or therapies for FCMSU. Staying informed about ongoing research and clinical trials could provide valuable insights into potential future treatments.

References

The information provided is based on the search results, which do not specifically mention drug treatment for Uruguay faciocardiomyoskeletal syndrome. The general information available might be useful in understanding rare disorders, but it's essential to consult medical professionals for accurate and specific guidance.

Citations:

  • [3] - The platform allows testing and optimization of medical treatment to maximize positive therapeutic outcomes.
  • [8] - Uruguay faciocardiomyoskeletal syndrome (FCMSU) is an X-linked disorder in which affected males have a distinctive facial appearance, muscular hypertrophy, ...

Recommended Medications

  • No Specific Treatment Mentioned
  • General Information on Rare Disorders
  • Consulting Medical Professionals
  • Research and Clinical Trials

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Uruguay faciocardiomusculoskeletal syndrome (FCMSU) is a rare X-linked disorder characterized by distinctive facial features, muscular hypertrophy, and cardiac ventricular hypertrophy leading to premature death. When considering differential diagnosis for FCMSU, several conditions should be taken into account.

  • Pettigrew syndrome: This developmental and epileptic encephalopathy condition shares some similarities with FCMSU in terms of its X-linked inheritance pattern.
  • Alpha-thalassemia: Although primarily associated with blood disorders, alpha-thalassemia can also present with skeletal and cardiac abnormalities, making it a potential differential diagnosis for FCMSU.
  • X-linked intellectual disability syndrome: This condition is characterized by intellectual disability, which may be relevant in cases where FCMSU patients exhibit cognitive impairments.
  • FG syndrome: Also known as Opitz-Frias syndrome, this rare X-linked disorder presents with distinct facial features and developmental delays, making it a potential differential diagnosis for FCMSU.
  • MEHMO syndrome: This condition is characterized by microcephaly, epilepsy, and hypomyelination, which may be relevant in cases where FCMSU patients exhibit neurological symptoms.
  • Intellectual developmental disorder, X-linked, Turner type: This condition presents with intellectual disability and distinctive facial features, making it a potential differential diagnosis for FCMSU.
  • Myotubular myopathy, X-linked: Although primarily associated with muscle weakness, this condition can also present with cardiac abnormalities, making it a potential differential diagnosis for FCMSU.

These conditions should be considered in the differential diagnosis of Uruguay faciocardiomusculoskeletal syndrome (FCMSU), as they share some similarities with FCMSU in terms of their X-linked inheritance pattern or presentation of skeletal and cardiac abnormalities. [1][2][3][4][5][6][7][8][9][10][11][12]

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112148
core#notation
DOID:0112148
oboInOwl#hasDbXref
MIM:300280
IAO_0000115
A syndrome characterized by distinctive facial appearance, muscular hypertrophy, and cardiac ventricular hypertrophy that has_material_basis_in hemizygous mutation in the FHL1 gene on chromosome Xq26.3.
oboInOwl#hasExactSynonym
FCMSU
rdf-schema#label
Uruguay faciocardiomusculoskeletal syndrome
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_225
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6658
owl#annotatedSource
t384249

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.